(CSD) Following a review of the PMTAs submitted by the company, the agency determined that authorizing these reduced nicotine products for sale in the U.S. is appropriate for the protection of the public health because of the potential to reduce nicotine dependence in adult smokers. Continued
Posts
No comments:
Post a Comment